We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$31.8B
AUM Growth
+$145M
Cap. Flow
-$898M
Cap. Flow %
-2.82%
Top 10 Hldgs %
5.32%
Holding
3,043
New
137
Increased
1,222
Reduced
1,432
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 11.47%
2 Healthcare 11.35%
3 Consumer Discretionary 10.7%
4 Financials 10.46%
5 Consumer Staples 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTWS
1426
DELISTED
Connecticut Water Service Inc
CTWS
$2.48M 0.01%
44,116
-9,371
-18% -$457K
HCR
1427
DELISTED
Hi-Crush Inc. Common Stock
HCR
$2.48M 0.01%
189,635
+55,318
+41% +$451K
TTWO icon
1428
Take-Two Interactive
TTWO
$45.4B
$2.46M 0.01%
64,905
-13,217
-17% -$487K
ARDC
1429
Are Dynamic Credit Allocation Fund
ARDC
$297M
$2.46M 0.01%
179,007
+25,893
+17% +$355K
ALGT icon
1430
Allegiant Air
ALGT
$2.64B
$2.45M 0.01%
16,171
+4,073
+34% +$629K
RAD
1431
DELISTED
Rite Aid Corporation
RAD
$2.45M 0.01%
16,346
+641
+4% +$101K
BCC icon
1432
Boise Cascade
BCC
$2.69B
$2.44M 0.01%
106,131
+41,451
+64% +$906K
HE icon
1433
Hawaiian Electric Industries
HE
$2.23B
$2.43M 0.01%
74,128
+8,843
+14% +$291K
ZAYO
1434
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$2.43M 0.01%
87,040
+16,721
+24% +$445K
BNED icon
1435
Barnes & Noble Education
BNED
$431M
$2.43M 0.01%
2,394
+78
+3% +$74K
COHR icon
1436
Coherent
COHR
$51.4B
$2.43M 0.01%
129,557
-3,311
-2% -$67.7K
SUP
1437
DELISTED
Superior Industries International
SUP
$2.43M 0.01%
90,728
-3,218
-3% -$82.5K
WBK
1438
DELISTED
Westpac Banking Corporation
WBK
$2.42M 0.01%
109,576
-7,092
-6% -$159K
TFX icon
1439
Teleflex
TFX
$6.05B
$2.42M 0.01%
13,643
-2,727
-17% -$445K
MASI
1440
DELISTED
Masimo
MASI
$2.41M 0.01%
45,903
-2,496
-5% -$118K
DAN icon
1441
Dana Inc
DAN
$2.9B
$2.41M 0.01%
228,183
-7,144
-3% -$88.1K
RIO icon
1442
Rio Tinto
RIO
$158B
$2.41M 0.01%
76,988
+17,158
+29% +$512K
VLT icon
1443
Invesco High Income Trust II
VLT
$64.9M
$2.41M 0.01%
175,140
+13,366
+8% +$183K
FPRX
1444
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.41M 0.01%
+58,199
New +$2.53M
ANDX
1445
DELISTED
Andeavor Logistics LP
ANDX
$2.41M 0.01%
48,597
-72,577
-60% -$3.42M
PTLA
1446
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.4M 0.01%
101,806
+5,157
+5% +$127K
MAIN icon
1447
Main Street Capital
MAIN
$5.06B
$2.4M 0.01%
73,016
-11,450
-14% -$365K
THC icon
1448
Tenet Healthcare
THC
$20.5B
$2.4M 0.01%
86,714
-1,135,025
-93% -$33.5M
PCRX icon
1449
Pacira BioSciences
PCRX
$1.04B
$2.39M 0.01%
70,968
+5,790
+9% +$285K
CCRN
1450
DELISTED
Cross Country Healthcare
CCRN
$2.39M 0.01%
171,422
-12,361
-7% -$164K

Similar funds

Guggenheim Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Guggenheim Capital held 3,043 positions worth $31.8B, up 0.46% from $31.7B the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.

Guggenheim Capital's Q2 2016 filing shows 137 new, 1,222 increased, 1,432 reduced and 170 closed positions. Its largest new stake was S&P Global: 471,834 shares worth $50.6M. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $66.9M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q2 2016 buy was S&P Global: 471,834 shares worth $50.6M.
  • Guggenheim Capital added most to Global Payments in Q2 2016, an estimated $45.5M increase.
  • Guggenheim Capital's biggest Q2 2016 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $66.9M.
  • Guggenheim Capital fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $51.1M.
  • Guggenheim Capital's ten largest holdings make up 5.3% of its $31.8B portfolio in Q2 2016.
  • Guggenheim Capital opened 137 new positions and closed 170 in Q2 2016.
  • Guggenheim Capital's portfolio value rose 0.46% quarter-over-quarter to $31.8B.

Based on Guggenheim Capital's 13F filing for Q2 2016, filed 15 Aug 2016.